Pharsight

Ani Pharms patents expiration

1. Veregen patents expiration

VEREGEN Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10434059 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Nov, 2022

(10 months ago)

US9770406 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Jul, 2025

(1 year, 9 months from now)

US7858662 ANI PHARMS Medicament for the treatment of viral skin and tumour diseases
Oct, 2026

(3 years from now)

Drugs and Companies using SINECATECHINS ingredient

Market Authorisation Date: 31 October, 2006

Treatment: Treatment of genital warts

Dosage: OINTMENT;TOPICAL

More Information on Dosage

VEREGEN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic